Impact Biomedical Stock Technical Analysis
| IBO Stock | USD 0.45 0.03 6.25% |
As of the 14th of February 2026, Impact BioMedical retains the insignificant Risk Adjusted Performance, standard deviation of 7.43, and Market Risk Adjusted Performance of (0.22). Impact BioMedical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Impact BioMedical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Impact, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImpactImpact BioMedical's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Will Biotechnology sector continue expanding? Could Impact diversify its offerings? Factors like these will boost the valuation of Impact BioMedical. Market participants price Impact higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Impact BioMedical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Impact BioMedical's market price often diverges from its book value, the accounting figure shown on Impact's balance sheet. Smart investors calculate Impact BioMedical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Impact BioMedical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Impact BioMedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Impact BioMedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Impact BioMedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Impact BioMedical.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Impact BioMedical on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Impact BioMedical or generate 0.0% return on investment in Impact BioMedical over 90 days. Impact BioMedical is related to or competes with Neurosense Therapeutics, AIM ImmunoTech, Brainstorm Cell, Alaunos Therapeutics, Moolec Science, Cyclerion Therapeutics, and Quoin Pharmaceuticals. Impact BioMedical is entity of United States More
Impact BioMedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Impact BioMedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Impact BioMedical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 61.57 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 8.0 |
Impact BioMedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Impact BioMedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Impact BioMedical's standard deviation. In reality, there are many statistical measures that can use Impact BioMedical historical prices to predict the future Impact BioMedical's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (0.23) |
Impact BioMedical February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.22) | |||
| Mean Deviation | 4.09 | |||
| Coefficient Of Variation | (7,602) | |||
| Standard Deviation | 7.43 | |||
| Variance | 55.24 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (0.23) | |||
| Maximum Drawdown | 61.57 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 8.0 | |||
| Skewness | 4.1 | |||
| Kurtosis | 26.25 |
Impact BioMedical Backtested Returns
Impact BioMedical appears to be out of control, given 3 months investment horizon. Impact BioMedical holds Efficiency (Sharpe) Ratio of 0.032, which attests that the entity had a 0.032 % return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Impact BioMedical, which you can use to evaluate the volatility of the firm. Please utilize Impact BioMedical's Standard Deviation of 7.43, insignificant risk adjusted performance, and Market Risk Adjusted Performance of (0.22) to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Impact BioMedical holds a performance score of 2. The company retains a Market Volatility (i.e., Beta) of 0.47, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Impact BioMedical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Impact BioMedical is expected to be smaller as well. Please check Impact BioMedical's potential upside, as well as the relationship between the daily balance of power and price action indicator , to make a quick decision on whether Impact BioMedical's current trending patterns will revert.
Auto-correlation | -0.38 |
Poor reverse predictability
Impact BioMedical has poor reverse predictability. Overlapping area represents the amount of predictability between Impact BioMedical time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Impact BioMedical price movement. The serial correlation of -0.38 indicates that just about 38.0% of current Impact BioMedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.38 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Impact BioMedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Impact BioMedical Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Impact BioMedical across different markets.
About Impact BioMedical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Impact BioMedical on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Impact BioMedical based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Impact BioMedical price pattern first instead of the macroeconomic environment surrounding Impact BioMedical. By analyzing Impact BioMedical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Impact BioMedical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Impact BioMedical specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2025 | 2026 (projected) | Days Sales Outstanding | 28.81 | 25.93 | 23.05 | PTB Ratio | 14.22 | 12.79 | 11.38 |
Impact BioMedical February 14, 2026 Technical Indicators
Most technical analysis of Impact help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Impact from various momentum indicators to cycle indicators. When you analyze Impact charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.22) | |||
| Mean Deviation | 4.09 | |||
| Coefficient Of Variation | (7,602) | |||
| Standard Deviation | 7.43 | |||
| Variance | 55.24 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (0.23) | |||
| Maximum Drawdown | 61.57 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 8.0 | |||
| Skewness | 4.1 | |||
| Kurtosis | 26.25 |
Impact BioMedical February 14, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Impact stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1,489 | ||
| Daily Balance Of Power | (1.50) | ||
| Rate Of Daily Change | 0.94 | ||
| Day Median Price | 0.45 | ||
| Day Typical Price | 0.45 | ||
| Price Action Indicator | (0.01) |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Will Biotechnology sector continue expanding? Could Impact diversify its offerings? Factors like these will boost the valuation of Impact BioMedical. Market participants price Impact higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Impact BioMedical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Impact BioMedical's market price often diverges from its book value, the accounting figure shown on Impact's balance sheet. Smart investors calculate Impact BioMedical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Impact BioMedical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Impact BioMedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.